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The clinical diagnosis of acute venous throm-
boembolism (VTE), i.e. of pulmonary embolism
(PE) or deep vein thrombosis (DVT), has been
viewed as a clinical challenge for many years [1–4].
Invasive investigations are considered the “gold
standard”, but they are expensive and associated
with a procedural risk [5, 6]. Moreover, they are not
always available in primary or secondary care set-
tings. The measurement of D-dimers (DD), prod-
ucts of fibrin degradation that increase in venous
thromboembolism [7], is a major innovation, that
has recently improved the diagnostic work-up of
acute thromboembolism. Though many different
assays are currently available, one of the most reli-
able testing methods is the rapid enzyme-linked
immunosorbent assay [8]. A negative result, de-
fined as less than or equal to 500 mg/l, has been
demonstrated to have a very high negative predic-
tive value (NPV) in the exclusion of acute throm-
boembolism in outpatients [8–12]. 
Before encouraging the widespread dissemina-
tion and implementation of a new diagnostic tech-
nique, its performance should be assessed in detail
in order to avoid premature introduction and inap-
propriate use in clinical practice [13–15]. This
process, which can be compared to the develop-
ment of a new drug, is a stepwise evaluation of the
test performances. The first phase allows the stan-
dardization of the procedure and the characteriza-
tion of normal values. In the second phase, the di-
agnostic accuracy of the test is prospectively evalu-
ated in a blinded manner in a large population of
Background: The performance of rapid D-
dimer ELISA assay has been validated as a part of
various diagnostic work-ups in tertiary care hospi-
tals for the exclusion of acute thromboembolism in
the medical emergency department. In order to
measure the performance of this test outside of pre-
determined protocols and in a different medical
setting, we retrospectively analysed a cohort of
adult patients admitted to the emergency depart-
ment of a regional hospital with a suspicion of acute
venous thromboembolism.
Methods: All D-dimer assays performed during
an 18-month period were retrieved. The patients’
data were collected from hospital charts. Six-month
follow-up was determined either by a written or
telephone questionnaire or after contact with the
patient’s physician. The patients for whom this
process was completed were included in the study
and a retrospective diagnostic assessment was per-
formed using a combination of clinical probability
and objective testing. The diagnosis was then com-
pared to the result of the initial D-dimer assay.
Results: During the study period 494 patients
were included with 110 venous thromboembolic
episodes. The sensitivity and negative predictive
value of the D-dimer assay were respectively 94.5%
(95% CI 88.4 to 97.7%) and 96.8% (95% CI 93.2
to 98.7%).
Conclusions: The yield of the rapid D-dimer
assay in this study is comparable to the results of
management studies performed in tertiary centres.
D-dimer ELISA assay can be used to exclude ve-
nous thromboembolism, particularly in cases with
a low clinical probability, in the emergency depart-
ment and for larger populations in various clinical
settings, even in the absence of a formal diagnostic
work-up. False negative results can occur, particu-
larly in the presence of a high clinical probability of
acute thromboembolism.
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patients. Eventually, the test must be used in man-
agement studies in which therapeutic decisions are
based on its result. In the case of D-Dimer assays,
these two first phases have been completed [13].
These assays have now been evaluated as part of
various diagnostic strategies in management stud-
ies, but have only been performed in tertiary cen-
tres as part of a strict diagnostic work-up (Table 1).
The generalization of these results to other diag-
nostic strategies in different clinical setting is there-
fore not straightforward. 
To evaluate the performance of a rapid quanti-
tative D-Dimer assay in a non university-affiliated
clinical setting with a less selected group of patients
in the absence of a standardized diagnostic strategy,
we developed a retrospective cohort study investi-
gating its yield in the emergency department (ED)
of a secondary care hospital.
Methods
The study was a retrospective, cohort analysis of med-
ical data from individual patients admitted to the emer-
gency department (ED) with suspicion of acute VTE. The
primary outcome of interest was the occurrence of DVT
or PE during a six-month follow-up period. The Ethics
Committee of the institution approved the protocol.
The study was conducted at the ED of the Regional
Hospital of Sion, Switzerland, a 250-bed regional hospital
with a population recruitment of 70,000 people and an an-
nual emergency admission rate of 7,500 patients. We ret-
rospectively selected from a computer database all adult pa-
tients (over 18 years old) who presented at the ED between
January 1997 and May 1998 with suspicion of acute VTE
and for whom a D-dimer assay was performed on admis-
sion (Figure 1). Patients for whom we could retrieve pre-
cise and complete data for a six-month period after the
index visit were included in the study. We excluded patients
with an incomplete follow-up as well as hospitalised and
surgical emergency patients.
For each patient, the 6-month history following the
index admission at the ED was retrieved. For that purpose,
the ED and hospital charts of patients were analysed. The
clinical evaluation (pre-test probability of VTE, as re-
ported by the emergency physician in charge of the patient
on admission) and the results of the invasive or non-inva-
sive tests were reported, as well as the discharge diagnosis.
Secondly, in order to complete the six-month follow-up,
we contacted all selected patients by mail and sent written
questionnaires to obtain information on any clinical event
during this period. Uncertain information was confirmed
by contact with the patient’s physician. Patients who did
not answer were eventually contacted by telephone. If this
was unsuccessful, we retrieved the family physician’s name
from the hospital charts and sent him a specific question-
naire. All medical notes of the study patients who were fur-
ther hospitalised were also reviewed for a diagnosis of acute
VTE. 
For each patient the occurrence of an acute VTE, de-
fined as either a positive diagnosis (see above) in the ED or
within the six-month follow-up period was recorded. The
diagnosis had to be based on the clinical evaluation com-
bined with confirmatory tests as usually advocated (see
above). A similar approach has already been used in clini-
cal management studies evaluating the use of D-dimer as-
says [16].
In the ED the diagnosis of VTE was based on clinical
evaluation (pre-test probability) and on non-invasive (ve-
nous ultrasound or lung scan) or invasive (venous or pul-
monary angiography) confirmatory tests, according to
standard criteria [17–19]. D-dimer assay was progressively
introduced in the hospital for a test period that corresponds
to the study period. It was available in the ED but the re-
Reference setting patients DVT outcome NPV2
n PE1
Kearon [28] III3 445 DVT confirmed recurrent DVT or PE in a 3-month follow-up period 99.4 (96.9–100)
Wells [29] III 930 PE confirmed recurrent PE in a 3 month follow-up period 99.5 (99.1–100.0)
Perrier [11] III 918 DVT/PE confirmed recurrent PE in a 3 month follow-up period 98.7 (96.9–99.1)
Wijns [30] III 74 DVT DVT on immediate phlebography 100
Bernardi [31] III 946 DVT confirmed recurrent PE in a 3 month follow-up period 99.6 (99.1–100.0)
Perrier [8] III 671 PE confirmed recurrent PE in a 3 month follow-up period 99.0 (96.4–99.9)
Laaban [32] III 117 DVT/PE confirmed recurrent PE in a 3 month follow-up period 97
Janssen [33] III 132 DVT DVT on immediate phlebography 100
De Moerlose [26] III 195 PE confirmed recurrent PE in a 6 month follow-up period 100 (93.3–100.0)
Gavaud [34] III 80 DVT/PE not available 87
Rochemaure [35] III 126 DVT/PE DVT or PE on immediate angiogram 97
Tengborn [36] III 96 DVT DVT on immediate phlebography 97
Dale [37] III 92 DVT DVT on immediate phlebography 95
Quinn [38] III 36 PE PE on immediate pulmonary angiogram 100
Ginsberg [39] III 221 PE diagnostic work-up (lung scan and bilateral 100
impedance plethysmography)
1 DVT: deep vein thrombosis; PE: pulmonary embolism
2 NPV: negative predictive value (95% confidence interval)
3 III: tertiary medical setting
Table 1
Results of prospec-
tive studies on the
assessment of 
D-dimer ELISA
performance in the
emergency depart-
ment for patients
with suspected
venous thromboem-
bolism.
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sults of the test were not taken into account in the final
diagnosis by the physician in charge of the patient. The
diagnosis of VTE could also be made by a physician dur-
ing the follow-up period. In this case a confirmatory test,
such as venous ultrasound, lung scan, or pulmonary an-
giography, had to have been performed in order to confirm
the thromboembolic episode. When the diagnosis was
clinically based only, it was considered negative in the
analysis. 
The DD assay was an automated two-step, sandwich-
type, immunoenzymatic assay performed with an auto-
mated multiparametric Immunoassay System (VIDAS,
BioMérieux, France). The cut-off value for a positive re-
sult was 500 mg/l. The instrument was automatically cali-
brated every 14 days and quality controls were regularly
done, according to the guidelines of the Swiss Commission
on Quality in the Medical Laboratory (QUALAB).
The occurrence of a VTE embolism during the fol-
low-up period was compared with the results of the DD
assay. In patients who had a negative D-dimer result and a
positive diagnosis of acute thromboembolism (“false neg-
ative cases”), the clinical data (medical and paramedical
charts, laboratory and blood gas analysis, ECG and chest
X-ray) and objective examinations (ventilation/perfusion
scan, pulmonary angiograms, venous ultrasound, chest
CT-scan) were reassessed in a blinded manner. Firstly, the
clinical probability was estimated by two experienced
physicians, working in the ED of a tertiary university hos-
pital, who were unaware of the aims of the study. They
rated the clinical probability as low (less than 20% chance
of thromboembolism), intermediate (20 to 80%) or high
(over 80%) following conventional clinical criteria [20, 21].
Secondly, two blinded specialists analysed the radiological
documents, without knowing the clinical probability of
VTE and the results of the original report. Ventilation/per-
fusion lung scans were rated on the number and localiza-
tion of mismatched perfusion defects [18]. Limb venous ul-
trasounds were considered positive if incompressibility of
a deep vein was described [4]. Pulmonary angiograms were
analysed applying the usual diagnostic criteria [22]. The
clinical probability and objective results were combined in
order to confirm or rule out the diagnosis of acute throm-
boembolic episode [18]. In case of doubt or inconclusive
results, the diagnosis was considered negative. 
After this evaluation process, patients were classified
in a 2-way contingency table (DD < or >500 mg/l, presence
Suspicion of DVT or PE
and DD assay performed at ED
605 patients
No diagnosis of DVT/PE
507 patients
Diagnosis of DVT or EP
98 patients
Lost to follow-up
111 patients
No diagnosis of DVT/PE
384 patients
Diagnosis of DVT/PE
110 patients
Negative
DD assay
180
patients
Positive
DD assay
204
patients
Negative
DD assay
6
patients
Positive
DD assay
104
patients
Complete
6-month follow-up
396 patients
STUDY POPULATION
494 patients
Figure 1
Selection and inclu-
sion of patients with
distribution of cases
of DVT/PE and result
of D-dimer assay.
DVT: Deep vein
thrombosis, PE: 
pulmonary em-
bolism, DD: D-dimer,
ED: emergency
department, Negative
DD assay: <500 mg/l,
Positive DD assay:
>500 mg/l
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or absence of VTE), and the operative characteristics of the
D-dimer assay were computed. Sensitivity, specificity, neg-
ative and positive predictive values with their respective
95% confidence intervals (CI) were calculated as previ-
ously described [23]. Groups of patients were compared by
using a Student t-test with a significant level at p <0.05.
Results
We retrieved the names of 605 patients, who
presented at the ED with a suspicion of acute VTE
and for whom a DD assay was performed in the ED
between January 1997 and May 1998 (Figure 1).
The complete 6-month follow-up could be ob-
tained for 494 patients (82%). 98 patients (16%)
were immediately admitted to the hospital and later
discharged with a diagnosis of VTE. Follow-up in-
formation was obtained for a further 396 patients
(87% by questionnaire, 7% from the family physi-
cian, and 6% by telephone). No information was
available for the remaining 111 patients (18%).
Thus the final study population included 494 pa-
tients (245 women and 249 men), with a mean age
of 61 ± 16 yrs. There were no significant differences
in the demographic (mean age, sex ratio) and clin-
ical (proportion of patient with a negative DD
assay) data between the study population and the
excluded subjects.
During the study period, 110 patients (22%)
had a positive diagnosis of acute VTE (Figure 1).
98 patients were discharged from the hospital with
this diagnosis and 12 presented with such an
episode during the six following months. In this
group of 110 patients, 104 had a positive (>500 mg/l)
D-dimer assay and 6 a negative result. The VTE
diagnosis was established at the initial ED admis-
sion for these six patients. The a posteriori evalua-
tion of the pre-test probability for these patients
was in agreement with the first clinical evaluation
made in the ED, and the reassessment of diagnos-
tic tests eventually confirmed the initial diagnosis
of acute thromboembolic episode (Table 2). These
patients were mostly young women with an inter-
mediate to high pre-test probability of PE, there
was either a history of previous thomboembolic
episode, a mean DD assay result (± SD) of 236 ± 93
mg/l, and/ or a conclusive lung scan, revealing at
least segmental mismatches. 
Based on this classification of patients (Figure
1), the sensitivity of the test is 94.5% (95% CI
88.4–97.7), with a negative predictive value of
96.8% (95% CI 93.2–98.7) (Table 3).
Age sex1 DD2 previous pre-test lung scan description test time of 
(yrs) (mg/l) DVT3or PE4 probability probability diagnosis
31 F 330 yes 20–80% multiple segmental mismatched defects high admission
33 F 184 yes >80% segmental mismatched defects high admission
51 F 110 no 20–80% multiple mismatched sub-segmental defects high admission
39 F 186 yes 20–80% lobar and segmental mismatched defects high admission
37 F 331 no 20–80% progressive multiple mismatched segmental defects high admission
72 M 274 yes >80% multiple lobar and segmental mismatched defects high admission
1 F: female; M: male
2 DD: D-dimers ELISA assay result
3 DVT: deep venous thrombosis
4 PE: pulmonary embolism
Table 2
Characteristics of the
six patients with a
negative DD test and
a final diagnosis of
PE.
Parameter result (95% CI)
Sensitivity 94.5% (88.4–97.7)
Specificity 46.9% (45.1–47.8)
Negative predictive value 96.8% (93.2–98.7)
Positive predictive value 33.8% (31.6–34.9)
Table 3
D-dimers ELISA
assay performance in
the study population.
Discussion
In this retrospective cohort study performed in
a secondary medical care setting, we included 494
adult patients who had a DD determination because
of suspicion of acute venous thromboembolism, and
for whom we could obtain complete information on
the six-month follow-up. 110 patients had a diag-
nosis of acute VTE, and of these, 6 had a negative
DD assay. The sensitivity and negative predictive
value of D-dimer ELISA assay were therefore
94.5% and 96.8% respectively. These values are
close to those of previous studies performed
prospectively in tertiary centres (Table 1), and con-
firm the usefulness of rapid D-dimer testing in un-
selected populations in various clinical settings with
no definite diagnostic protocol. Interestingly, we
found 6 false negative cases. The clinical probabil-
ity as judged by the ED physician and as confirmed
a posteriori, was either intermediate or high in all of
these cases. It is impossible to determine if all per-
fusion defects seen on the pulmonary scan where
new or if some of them were residual findings of pre-
vious episodes. The association of an intermediate
or high clinical probability combined with these re-
sults is, however, highly suggestive of acute PE. 
What do these results add to previous published
data and how can they be transposed to clinical prac-
tice? The evidence of false negative results of the
test in patients with intermediate to high clinical
suspicion of VTE is a first important point. All clin-
ical studies have evidenced a few false negative cases.
Therefore, if there is a high clinical suspicion of
VTE associated with a negative D-dimer assay, fur-
ther objective examinations should probably be per-
formed before excluding the diagnosis [3, 24].
A second important point to notice is that the
studied population is closer to “real-life” daily prac-
tice than in the published validation protocols. The
DD test was ordered more randomly than in a rig-
orous prospective study, depending mostly on the
prescribing physician, and was not always followed
by the same diagnostic work-up, owing to the dif-
fering availability of these procedures. This would
probably be the case in many emergency medical
settings, where some tests can only be performed
during certain periods of the day or of the week. In
such settings, the use of a rapid DD assay to exclude
an acute VTE seems to be reliable and its high NPV
is sufficient as an initial test, at least in patients with
a low clinical probability. Moreover, the use of such
a rapid assay as the only “around-the-clock” avail-
able test could be economically interesting, as it is
less expensive (50 Swiss Francs) than other objec-
tive tests and more easily performed, even in an in-
dependent laboratory located outside the hospital.
Patients with a negative result can be discharged
quickly and do not use hospital resources while wait-
ing for further tests. For the remaining patients, a
second diagnostic step is necessary and is dependant
on the availability of each procedure. 
In this study, which included patients during a
17-month period, VTE was confirmed in 110 pa-
tients, corresponding to the usual incidence of one
case per 1,000 person-year [25]. During the same
period, the rapid DD test was performed on around
5% of the admitted patients. The result of the test
was negative in 38% of the patients, mostly in cases
with a low clinical probability of VTE. It can there-
fore be estimated that a rapid DD assay could be
useful in allowing around one third of patients with
a suspicion of VTE to be discharged without any
further procedure, representing one of fifty medical
patients admitted to the ED. This proportion is,
however, highly dependent on the careful selection
of patient for whom the test is prescribed. A rapid
DD test should probably not be performed in pa-
tients with a high clinical suspicion of VTE, as a
negative result does not avoid further investigations.
In conclusion, the introduction of a rapid DD assay
as the only available test for the diagnosis work-up
of VTE could be economically interesting for emer-
gency medical units (hospital or ambulatory prac-
tice), if the patient load and the prevalence of VTE
are sufficient and if the selection of patients for
whom the test is prescribed is performed carefully. 
This study has some limitations. Firstly, the ret-
rospective approach is exposed to reporting bias, so
that the assignment of patients in the groups of true
and false cases may be slightly different. DD-ELISA
is very useful to exclude the diagnosis of DVT or
PE because of its high negative predictive value,
which is mainly influenced by the number of false
negative cases. The probability that such cases
would have been missed in our cohort is low. The
absence of an invasive gold standard for the diag-
nosis of venous thromboembolism is further limita-
tion of this study. However, this method of analysing
the occurrence of DVT or PE during follow-up has
been previously used in the literature [8, 11, 26, 27].
Finally, we did not include the 111 patients for
whom we could obtain no information on the fol-
low-up in the analysis. These patients were not sig-
nificantly different from those included. 44 of them
had a negative DD assay (<500 mg/l). No episode of
acute thromboembolism was initially diagnosed in
these patients and the risk of one of these patients,
presenting with a thromboembolic episode during
the follow-up period, not being investigated and
treated in the same hospital is, for geographical rea-
sons, very low. Despite these limitations, this study
confirms the usefulness of a rapid DD test in the ex-
clusion of acute venous thromboembolic disease in
a non-tertiary centre, even in the absence of any fur-
ther formal standardized diagnostic strategy. 
Pulmonary embolism and deep vein thrombo-
sis are difficult diagnoses in the emergency depart-
ment, although the development of less invasive and
more reliable tests has made this process easier. D-
dimer ELISA has been shown to have a high nega-
tive predictive value in prospective studies per-
formed in tertiary centres. In this retrospective
study, we show that the recognized performance of
D-dimer ELISA can be transposed to a secondary
clinical setting and that this test can be proposed as
the initial diagnostic step in the evaluation of clini-
cal suspicion of acute venous thromboembolism in
most clinical settings.
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